Vitality Watch

⚠ Evidence note: An aging clock is a statistical model, not a measurement of aging itself; predictive validity varies widely between clocks and populations.

Mentioned 30× · first seen 27-sep-2026 · last seen 16-nov-2026

Senescent Burden Biomarkers and Imaging

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-11-12 — Transcriptomic Characterization of Cellular Senescence in Human Donor Livers Before Transplantation: [human-observational] Observational transcriptomic profiling of human donor livers before transplantation characterizes tissue-specific senescence-associated signatures as candidate indicators of organ aging and graft quality, but the supplied finding does not establish graft-outcome prediction, test–retest reliability, direct senescent-cell quantification, or intervention responsiveness. [human-observational] (novelty: 3)
  • 2026-11-01 — Enabling Photoacoustic Imaging and Photothermal Elimination of Senescent Cells via an Activatable Theranostic Probe.: [animal-model] Preclinical in vivo study reports that RPM-Gal, activated by senescence-associated β-galactosidase, enables photoacoustic imaging and photothermal elimination of senescent cells, extending the imaging-and-treatment toolkit without establishing human outcome prediction, test–retest reliability, or that probe activation or targeted cell elimination demonstrates de-aging. [animal-model] (novelty: 3)
  • 2026-11-11 — A genetically encoded system to purify senescent cells.: [mechanism-plausible] In vitro methods study introduces SenLect, a miR-146a-promoter–driven puromycin-selection system for purifying senescent cells from mixed cultures for proteomic, metabolic, and secretomic profiling, addressing proliferating-cell contamination without establishing clinical senescent-burden measurement, human outcome prediction, or evidence that changing a senescence signature means de-aging. [mechanism-plausible] (novelty: 3)
  • 2026-10-28 — Identification of an Endothelial Senotype Predicted by Ion Channel Expression in Aged Murine Perigonadal Adipose Tissue.: [animal-model] Single-nucleus RNA sequencing of aged mouse perigonadal adipose tissue identified a senescence-associated endothelial capillary subpopulation with elevated Mif expression and predictive ion-channel transport gene profiles, adding candidate tissue-specific senotype markers without establishing whole-body senescent-burden measurement, human outcome prediction, or intervention responsiveness. [animal-model] (novelty: 3)
  • 2026-10-08 — Biomarker-Guided, Stage-Specific Senotherapy for Metabolic Dysfunction-Associated Steatotic Liver Disease.: Perspective proposes a stage-specific, biomarker-stratified senotherapy framework for MASLD, sequencing short-term senolytic clearance with long-term senomorphic maintenance and dividing senescence biomarkers into selection, timing, and response categories tied to disease stage — hypothesis-generating translational framing, no new empirical data on whether any proposed biomarker tracks de-aging or treatment benefit. [expert-opinion] (novelty: 3)
  • 2026-09-30 — An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer: Open-label pilot in adult childhood-cancer survivors uses blood p16INK4a as the pharmacodynamic senescence readout for short-course D+Q and fisetin regimens, paired with gait-speed/frailty endpoints — extends p16INK4a-based senescent-burden quantification into a survivor population as a trial endpoint, but no efficacy data yet so this is a design signal, not evidence the marker tracks de-aging. [mechanism-plausible] (novelty: 3)
  • 2026-10-01 — Precision Microbiota Interventions for Senoreduction Trial: Registered randomized double-blind crossover trial testing two GRAS microbiota-targeted interventions on immune-senescence biomarkers in people with HIV who drink alcohol — adds senescence panels (plasma SASP/immune-senescence readouts) as pharmacodynamic endpoints in a senoreduction probe, but no readout yet so this is a trial design signal rather than evidence that the biomarkers move or that movement means de-aging. [mechanism-plausible] (novelty: 3)
  • 2026-09-28 — A New Metric for Overall Senescent Cell Burden: Secondary news coverage of the deep-learning SASP Score reiterates it as a blood-borne composite quantifying overall circulating senescent-cell burden from SASP factors — no new primary data beyond the already-logged study, extends press-level visibility of the SASP-score modality. [expert-opinion] (novelty: 3)
  • 2026-10-05 — Prediction of Oxidative Stress- and Anticancer Drug-Induced Cellular Senescence Using Holotomography and Interpretable Attention-Based Contrastive Learning.: BICAN-HT applies interpretable attention-based contrastive learning to label-free holotomography of two cell lines, quantifying H2O2-, doxorubicin-, and palbociclib-induced senescence from nucleus–cytoplasm morphology and reportedly outperforming prior models — adds a label-free, interpretable in vitro imaging readout to the senescence-quantification toolkit but is preclinical cell-line work with no in vivo or human validation. [mechanism-plausible] (novelty: 3)
  • 2026-10-01 — Deep Learning Predicts Hematopoietic Stem Cell Aging From 3D Chromatin Images.: ChromAgeNet reads 3D DAPI chromatin architecture (entropy, peripheral heterochromatin, condensates) in murine HSCs as a single-cell imaging surrogate for an aging/senescence-adjacent phenotype and is pitched as a screening readout for epigenetic rejuvenation compounds — adds a nuclear-architecture imaging layer to the senescent-burden toolkit, but ‘rejuvenation phenotype’ here means classifier-score reversal, not demonstrated loss of senescent cells. [animal-model] (novelty: 3)
  • 2026-05-22 — circRNA-engineered macrophages mediate localized MMP9 neutralization to rejuvenate aged bone.: Aged-mouse study used stem-cell senescence and SASP factors as readouts to validate a circRNA-LNP macrophage-biofactory delivering anti-MMP9 antibodies, with concurrent bone/cartilage rejuvenation endpoints — animal preclinical, extends the use of senescence/SASP panels as pharmacodynamic readouts for novel senomorphic-adjacent modalities but does not validate the biomarkers themselves. [animal-model] (novelty: 4)
  • 2026-07-11 — Cellular viscous properties in senescence: An emerging biophysical perspective and potential biomarker.: Review argues cellular viscous properties (not just elastic stiffness) shift during senescence and could complement SA-β-gal/SASP panels as biophysical biomarkers for senescence detection and senolytic response — methods survey only, no new primary human or animal data. [mechanism-plausible] (novelty: 3)
  • 2026-07-14 — A compendium of circulating biomarkers of senescence in humans: Insights on mechanistic impact across health domains and modulation by therapeutic interventions.: Human-focused compendium of circulating senescence biomarkers consolidates cross-study plasma SASP factors (notably GDF15 and Activin A) as noninvasive indices of senescence burden with associations across neurodegeneration, pulmonary, cardiometabolic, and musculoskeletal decline, and some evidence of modulation by senotherapeutics — synthesis of prior human observational data, no new primary results. [expert-opinion] (novelty: 3)
  • 2026-07-14 — Mechanical signals in aging: mechanisms and therapeutic strategies.: Review frames cellular mechanics and mechanotransduction (stiffness, cytoskeletal tension, nuclear mechanics) as upstream regulators of senescence initiation/progression, suggesting mechanical phenotypes could serve as complementary senescence readouts alongside SA-β-gal, SASP, and p16/p21 panels — synthesis only, no new quantification. [mechanism-plausible] (novelty: 3)
  • 2026-08-02 — Brain aging clocks: From methodological advances to cellular mechanisms.: cross-connection with brain-age-neuroimaging: Review explicitly links brain aging clock acceleration to cellular senescence burden as a candidate mechanistic driver, bridging imaging-derived brain-age gap and senescence-burden readouts that are usually developed in parallel silos. (novelty: 3)
  • 2026-07-19 — The circulating senosome: Blood as the therapeutic interface of aging.: Conceptual review proposes the ‘circulating senosome’ — a composite blood-borne network (senescence, inflammatory, metabolic, microbial, and nucleic-acid mediators) — positioning senescent-burden readouts as one layer inside a broader plasma signal rather than a standalone compartment; synthesis only, no new quantification data. [expert-opinion] (novelty: 3)
  • 2026-07-04 — Effects of nutritional interventions on biomarkers of cellular senescence in humans: A systematic review.: Systematic review of 27 human nutritional intervention trials finds calorie restriction and related dietary strategies more consistently shift SASP/inflammatory senescence-associated markers (IL-6, TNF-α, CRP) than classical senescent-cell abundance markers (p16, p21, telomere length), suggesting current human readouts of ‘senescent burden’ in nutrition trials are largely secretome-based rather than cell-count-based. [human-observational] (novelty: 3)
  • 2026-10-01 — A Deep-Learning Based Biomarker of Systemic Cellular Senescence Burden to Predict Mortality and Health Outcomes.: cross-connection with omics-aging-signatures: The SASP Score operationalizes systemic senescence burden as a plasma proteomic composite, bridging the senescence-biomarker toolkit with proteomic aging signatures. (novelty: 4)
  • 2026-09-26 — A Deep‐Learning Based Biomarker of Systemic Cellular Senescence Burden to Predict Mortality and Health Outcomes: Deep-learning biomarker of systemic cellular senescence burden reported to predict mortality and health outcomes in observational data — adds a computational scoring approach to the in vivo/liquid-biopsy senescence quantification toolkit, but predictive validity is association-level, not a demonstration that lowering the score improves outcomes. [human-observational] (novelty: 3)
  • 2026-09-16 — Retrotransposable element derepression distinguishes DNMT3A-mutant from TET2-mutant clonal haematopoiesis.: cross-connection with clonal-hematopoiesis: DNMT3A-mutant CHIP’s RTE derepression links to senescence-associated inflammatory signatures, suggesting overlap between CHIP-driven and senescence-driven inflammaging measurements. (novelty: 3)

Open questions

Related

Contributing findings

clinicaltrials observational
Vascular Aging and Microcirculation: Physiological Aspects of Vascular Aging in the Elderly Population (VAMP-Aging)
13-nov-2026 novelty 2 per-area 2 introduces
pubmed review
Cellular senescence and the hallmarks of ageing: Evaluating evidence for a causal mechanistic role.
13-nov-2026 novelty 3 per-area 2 mentions
rss observational human-observational
Transcriptomic Characterization of Cellular Senescence in Human Donor Livers Before Transplantation
12-nov-2026 novelty 3 per-area 3 strengthens
pubmed preclinical mechanism-plausible
A genetically encoded system to purify senescent cells.
11-nov-2026 novelty 3 per-area 3 strengthens
pubmed preclinical
Senescent CD8 T effector memory cells are functionally impaired, enriched in aging and disease, and a barrier to immunotherapy.
03-nov-2026 novelty 3 per-area 2 strengthens
pubmed preclinical animal-model
Enabling Photoacoustic Imaging and Photothermal Elimination of Senescent Cells via an Activatable Theranostic Probe.
01-nov-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
Identification of an Endothelial Senotype Predicted by Ion Channel Expression in Aged Murine Perigonadal Adipose Tissue.
28-oct-2026 novelty 3 per-area 3 strengthens
pubmed review expert-opinion
Biomarker-Guided, Stage-Specific Senotherapy for Metabolic Dysfunction-Associated Steatotic Liver Disease.
08-oct-2026 novelty 3 per-area 3 strengthens
pubmed preclinical mechanism-plausible
Prediction of Oxidative Stress- and Anticancer Drug-Induced Cellular Senescence Using Holotomography and Interpretable Attention-Based Contrastive Learning.
05-oct-2026 novelty 3 per-area 3 strengthens
pubmed review
Cellular senescence: six decades of discovery and reinvention.
02-oct-2026 novelty 2 per-area 2 mentions
clinicaltrials trial early mechanism-plausible
Precision Microbiota Interventions for Senoreduction Trial
01-oct-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
Deep Learning Predicts Hematopoietic Stem Cell Aging From 3D Chromatin Images.
01-oct-2026 novelty 3 per-area 3 strengthens
pubmed review
The Role of EVs in the Aging Hematopoietic System.
01-oct-2026 novelty 2 per-area 2 mentions
pubmed review
Future directions of osteoanabolic therapies in osteoporosis: Integrating current anabolic agents and emerging senescence-targeted strategies.
01-oct-2026 novelty 2 per-area 2 strengthens
pubmed observational
A Deep-Learning Based Biomarker of Systemic Cellular Senescence Burden to Predict Mortality and Health Outcomes.
01-oct-2026 novelty 4 per-area 4 introduces
clinicaltrials trial early mechanism-plausible
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
30-sep-2026 novelty 3 per-area 3 strengthens
rss news report expert-opinion
A New Metric for Overall Senescent Cell Burden
28-sep-2026 novelty 3 per-area 3 strengthens
pubmed review
Stem cell senescence as a regenerative bottleneck in age-related skeletal degeneration: Mechanistic crosstalk and translational strategies.
27-sep-2026 novelty 2 per-area 2 strengthens
rss observational human-observational
A Deep‐Learning Based Biomarker of Systemic Cellular Senescence Burden to Predict Mortality and Health Outcomes
26-sep-2026 novelty 3 per-area 3 strengthens
clinicaltrials trial early
Human Albumin Combined With Plasma Exchange for Frailty Intervention
23-sep-2026 novelty 3 per-area 2 mentions
pubmed review
Nanoparticle-Based Tools to Study Hallmarks of Aging at the Molecular Level.
22-sep-2026 novelty 2 per-area 2 mentions
pubmed review
Multidimensional Regulatory Network of Cellular Senescence: From Mechanisms to Theranostics.
15-sep-2026 novelty 2 per-area 3 introduces
pubmed review
Senescent cell heterogeneity in brain aging and neurodegenerative disease.
21-jul-2026 novelty 2 per-area 3 strengthens
pubmed review expert-opinion
The circulating senosome: Blood as the therapeutic interface of aging.
19-jul-2026 novelty 3 per-area 3 strengthens
pubmed review expert-opinion
A compendium of circulating biomarkers of senescence in humans: Insights on mechanistic impact across health domains and modulation by therapeutic interventions.
14-jul-2026 novelty 3 per-area 3 strengthens
pubmed review mechanism-plausible
Mechanical signals in aging: mechanisms and therapeutic strategies.
14-jul-2026 novelty 3 per-area 3 strengthens
pubmed review
Accelerated aging in schizophrenia: integrating epigenetic clocks, telomere dynamics, senescence-associated secretory phenotype, and oxidative stress.
11-jul-2026 novelty 2 per-area 2 strengthens
pubmed review mechanism-plausible
Cellular viscous properties in senescence: An emerging biophysical perspective and potential biomarker.
11-jul-2026 novelty 3 per-area 3 strengthens
pubmed review human-observational
Effects of nutritional interventions on biomarkers of cellular senescence in humans: A systematic review.
04-jul-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
circRNA-engineered macrophages mediate localized MMP9 neutralization to rejuvenate aged bone.
22-may-2026 novelty 4 per-area 4 strengthens

build build 880 · 2bcef25 · 2026-11-18